DNA methylation profiling across six histological states of prostate cancer
Ontology highlight
ABSTRACT: In spite of its prevalence as one of the world’s leading malignancies, prostate cancer (PCa) continues to evade molecular taxonomic sub-classification. However, gross clinical differences are observed within the umbrella term ‘prostate adenocarcinoma’; the majority of tumors appear indolent in nature, whilst a subset manifest aggressively. Contributing factors towards this resistance to molecular classification are an atypically low mutation frequency and a poorly delineated pathobiology. Conversely, epigenetic changes are evidenced to be amongst the earliest and most-widespread aberrations in PCa . We thus hypothesized that delineating epigenomic alterations during the stepwise progression of PCa would improve our understanding of the disease pathobiology and the molecular underpinning of indolent and aggressive tumors. Herein, we report the first epigenomic roadmap of prostate tumorigenesis, in which we dissected DNA methylation and microRNA expression in enriched epithelial cells across the entire trajectory of PCa, through tumor initiation, primary disease and metastatic dissemination. We provide evidence in support of proliferative inflammatory atrophy (PIA) as a precursor lesion, distinct from high-grade prostatic intraepithelial neoplasia (HGPIN) and show that indolent and aggressive tumors display unique sets of epigenetically dysregulated loci, which we further investigated as potential discriminatory markers. This study also establishes the importance of DNA methylation beyond the gene promoter in human cancer, with pronounced intra- and inter-genic CpG methylation observed.
ORGANISM(S): Homo sapiens
PROVIDER: GSE116338 | GEO | 2021/06/25
REPOSITORIES: GEO
ACCESS DATA